This event is now apart of the Genetics Week Virtual Event Series.
Our 3rd Annual Event in the Molecular Diagnostics Virtual Event Series is now available On Demand! The Molecular Diagnostics Event is the premiere venue for scientists, technologists, and professionals to discuss and present the newest advances in molecular diagnostics testing.
Learn from keynote speaker and renown expert Dr. Eunice Lee, Branch Chief of Molecular Pathology and Cytology Branch with the FDA, and other experts like Dr. Steven Lee of University of California, Berkeley; Dr. Judd Moul from Duke University Medical Center; and Dr. Jason Kralj from NIST. Enjoy the complementary conference from your desk with no need for travel, and explore the virtual exhibit hall to learn about the latest technologies and techniques for your lab.
Topics in the 2018 event included:
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (CE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation, you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.
Produced on a new, more robust platform, you can watch, learn and connect during this conference on mobile devices easier than ever before. Equipped with a leaderboard and scavengerhunt, you can now move around the entire event earning points for a chance to win one of LabRoots most popular shirts
Use #LRmoldx to follow the conversation!
Branch Chief, Molecular Pathology & Cytology Branch, Division of Molecular Genetics & Pathology, Office of In Vitro Diagnostics & Radiological Health, FDA
James H Semans MD Professor of Surgery, Division of Urologic Surgery, Director, Duke Prostate Center, Duke Cancer Institute, Duke University Medical Center
Vice President and Chief Medical Officer, Genomic and Clinical Pathology Services, PathGroup
Professor, School for the Future of Innovation in Society and Consortium for Science, Policy & Outcomes, Arizona State University
Principal at Roger D. Klein, MD JD Consulting and Klein & Klein Co., L.P.A. Faculty Fellow at the Arizona State University Sandra Day O'Connor College of Law's Center for Law, Science &
Product Director, QIAGEN
Leader of the Metagenomic Pathogen Detection Program, National Institute of Standards and Technology
Senior Scientist, Biomedical Genomics, QIAGEN
Vice President, Business Development, Scienion
Professor, Department of Pathology and Laboratory Medicine, Women & Infants Hospital/Alpert Medical School at Brown University
Marketing Manager, Scienion
Scientific and General Director, Cellenion
Associate Professor of Medicine, Department of Molecular Genetics and Microbiology, Duke University School of Medicine
Professor and Chief Clinical Chemistry and Toxicology, Department of Pathology and Laboratory Medicine, University of Louisville School of Medicine
Assistant Professor, Molecular Biology & Biochemistry/Pediatrics, University of California, Irvine
Division Director for "Molecular and Microbial Diagnostics and Development", Department of Laboratory Medicine, Geisinger
DiaSorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics.
Delivering a better way to improve patient outcomes by enabling access to molecular diagnostic testing everywhere.
Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems dedicated to making genomics useful for all. Innovating at the intersection of technology, biology, and health, we are reimagining what's possible for human health and the ...See more See less
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological ...See more See less
For over 25 years, Aurora Biomed has been a global leader in the design and development of lab automation solutions for life science, environmental science, drug discovery/safety and chemical analysis research. We are committed to improving the quality of human and environmental ...See more See less
Bentham Science has three main operating divisions: subscription-based journals, open access titles, and e-books. We publish research literature in all areas of science, medicine, technology, humanities, and social sciences, which is available in both electronic and print ...See more See less
Dr. Cobb is the acting Director for Clinical Molecular Diagnostics at Roche Diagnostics Corporation where he serves in a scientific advisory role supporting the laboratory scientific community. He obtained his Ph.D. in Medical Genetics at the University of Alabama at Birmingham ...See more See less
Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench ...See more See less
The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...See more See less
Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...See more See less
Emily Hollister is the Director, R&D, Computational Biology for Diversigen. An accomplished microbial ecologist, her microbiome experience ranges from soils and biofuel production systems to the human microbiome and pre-clinical disease models. She leads a team of ...See more See less